BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4,661	7,023	1,139	2,455	8,716	4,331
Market Cap Growth	116.62%	516.56%	-53.60%	-71.84%	101.23%	-
Enterprise Value	5,870	8,311	2,353	3,344	8,605	3,877
PE Ratio	-	-10.92	-2.37	-4.36	-19.42	-16.62
PS Ratio	21.32	754.92	14.67	35.21	1056.59	106.79
PB Ratio	-5.18	-5.19	-0.91	-2.82	150.52	10.60
P/FCF Ratio	-8.99	-13.28	-3.62	-4.80	-21.40	-16.90
P/OCF Ratio	-9.02	-13.31	-2.72	-4.93	-21.81	-17.08
EV/Sales Ratio	26.85	893.41	30.30	47.97	1043.10	95.59
EV/EBITDA Ratio	-15.00	-15.07	-6.05	-6.63	-21.11	-15.45
EV/EBIT Ratio	-14.65	-14.79	-5.87	-6.48	-20.88	-15.40
EV/FCF Ratio	-10.99	-15.71	-7.49	-6.54	-21.13	-15.13
Debt / Equity Ratio	-1.65	-1.28	-1.37	-1.98	8.56	0.22
Debt / EBITDA Ratio	-3.90	-3.16	-4.43	-3.42	-1.22	-0.37
Debt / FCF Ratio	-2.86	-3.29	-5.48	-3.38	-1.22	-0.36
Quick Ratio	5.34	3.15	4.34	6.34	6.35	9.09
Current Ratio	5.54	3.32	4.52	6.58	6.72	9.42
Asset Turnover	0.34	0.02	0.10	0.07	0.01	0.08
Interest Coverage	-5.36	-6.91	-4.98	-11.03	-11.24	-28.73
Return on Equity (ROE)	43.30%	50.00%	43.20%	91.00%	-206.80%	-339.10%
Return on Assets (ROA)	-84.30%	-110.40%	-63.60%	-56.70%	-53.00%	-52.10%
Return on Capital (ROIC)	-69.40%	-157.52%	-109.22%	-67.38%	-85.69%	-53.22%
Earnings Yield	-11.55%	-9.16%	-42.24%	-22.92%	-5.15%	-6.02%
FCF Yield	-12.98%	-7.53%	-27.59%	-20.82%	-4.67%	-5.92%
Buyback Yield / Dilution	-17.07%	-10.39%	-2.16%	-22.34%	-12.27%	-70.15%
Total Shareholder Return	-17.07%	-10.39%	-2.16%	-22.34%	-12.27%	-70.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).